ANAVEX LIFE SCIENCES C

Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

17 10月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024

03 9月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update

06 8月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024

01 8月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference

30 7月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference

28 7月 2024 16:00:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

20 6月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Announces Expansion of Leadership Team

22 5月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ

14 5月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update

09 5月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

02 5月 2024 06:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

25 4月 2024 08:45:15 条件 NetDania Notify

NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK

24 4月 2024 08:50:00 条件 NetDania Notify

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

11 4月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

25 3月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia

18 3月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference

26 2月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update

07 2月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024

01 2月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans

24 1月 2024 06:30:00 条件 Nasdaq GlobeNewswire